 |
|
|
| |
Real-World Use of Ibalizumab in Physician Office infusion Centers (POICs)
|
| |
| |
Reported by Jules Levin
IDWeek 2019 Oct 2-6 Wash DC
IDWeek 2019: HIV Suppression and Safety With Ibalizumab at 48 Weeks in Expanded Access - (10/4/19)
Richard C. Prokesch, MD1; Claudia P. Schroeder, PharmD, PhD2; Thomas C. Hardin, PharmD2; Lucinda J. Van Anglen, PharmD2
1Infectious Disease Associates, Riverdale, Georgia; 2Healix Infusion Therapy, Sugar Land, Texas
|
| |
|
|
|
|
|
